The Current Role of Omega-3 Fatty Acids in the Management of Atrial Fibrillation

Background: The main dietary source of omega-3 polyunsaturated fatty acids (n-3 PUFA) is fish, which contains eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). In the present manuscript, we aimed to review the current evidence regarding the clinical role of n-3 PUFA in the prevention of at...

Full description

Bibliographic Details
Main Authors: Georgios A. Christou, Konstantinos A. Christou, Panagiotis Korantzopoulos, Evangelos C. Rizos, Dimitrios N. Nikas, John A. Goudevenos
Format: Article
Language:English
Published: MDPI AG 2015-09-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:http://www.mdpi.com/1422-0067/16/9/22870
id doaj-11c3e85c34914cfca9c9b2c33d68a6ce
record_format Article
spelling doaj-11c3e85c34914cfca9c9b2c33d68a6ce2020-11-24T22:22:24ZengMDPI AGInternational Journal of Molecular Sciences1422-00672015-09-01169228702288710.3390/ijms160922870ijms160922870The Current Role of Omega-3 Fatty Acids in the Management of Atrial FibrillationGeorgios A. Christou0Konstantinos A. Christou1Panagiotis Korantzopoulos2Evangelos C. Rizos3Dimitrios N. Nikas4John A. Goudevenos5Laboratory of Physiology, Medical School, University of Ioannina, 45110 Ioannina, GreeceFirst Department of Internal Medicine, University Hospital of Ioannina, 45110 Ioannina, GreeceFirst Department of Cardiology, University Hospital of Ioannina, 45110 Ioannina, GreeceSecond Medical Department and Outpatient Lipid Clinic, University Hospital of Ioannina, 45110 Ioannina, GreeceFirst Department of Cardiology, University Hospital of Ioannina, 45110 Ioannina, GreeceFirst Department of Cardiology, University Hospital of Ioannina, 45110 Ioannina, GreeceBackground: The main dietary source of omega-3 polyunsaturated fatty acids (n-3 PUFA) is fish, which contains eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). In the present manuscript, we aimed to review the current evidence regarding the clinical role of n-3 PUFA in the prevention of atrial fibrillation (AF) and the possible underlying mechanisms. Methods: A literature search based on PubMed listings was performed using “Omega-3 fatty acids” and “atrial fibrilation” as key search terms. Results: n-3 PUFA have been shown to attenuate structural atrial remodeling, prolong atrial effective refractory period through the prevention of reentry and suppress ectopic firing from pulmonary veins. Dietary fish intake has been found to have no effect on the incidence of AF in the majority of studies. Circulating DHA has been consistently reported to be inversely associated with AF risk, whereas EPA has no such effect. The majority of studies investigating the impact of n-3 PUFA supplementation on the incidence of AF following cardiac surgery reported no benefit, though most of them did not use n-3 PUFA pretreatment for adequate duration. Studies using adequate four-week pretreatment with n-3 PUFA before cardioversion of AF showed a reduction of the AF incidence. Conclusions: Although n-3 PUFA have antiarrhythmogenic properties, their clinical efficacy on the prevention of AF is not consistently supported. Further well-designed studies are needed to overcome the limitations of the existing studies and provide robust conclusions.http://www.mdpi.com/1422-0067/16/9/22870omega-3 fatty acidseicosapentaenoic aciddocosahexaenoic acidfish oilatrial fibrillationcardiac surgerycardioversionarrhythmia
collection DOAJ
language English
format Article
sources DOAJ
author Georgios A. Christou
Konstantinos A. Christou
Panagiotis Korantzopoulos
Evangelos C. Rizos
Dimitrios N. Nikas
John A. Goudevenos
spellingShingle Georgios A. Christou
Konstantinos A. Christou
Panagiotis Korantzopoulos
Evangelos C. Rizos
Dimitrios N. Nikas
John A. Goudevenos
The Current Role of Omega-3 Fatty Acids in the Management of Atrial Fibrillation
International Journal of Molecular Sciences
omega-3 fatty acids
eicosapentaenoic acid
docosahexaenoic acid
fish oil
atrial fibrillation
cardiac surgery
cardioversion
arrhythmia
author_facet Georgios A. Christou
Konstantinos A. Christou
Panagiotis Korantzopoulos
Evangelos C. Rizos
Dimitrios N. Nikas
John A. Goudevenos
author_sort Georgios A. Christou
title The Current Role of Omega-3 Fatty Acids in the Management of Atrial Fibrillation
title_short The Current Role of Omega-3 Fatty Acids in the Management of Atrial Fibrillation
title_full The Current Role of Omega-3 Fatty Acids in the Management of Atrial Fibrillation
title_fullStr The Current Role of Omega-3 Fatty Acids in the Management of Atrial Fibrillation
title_full_unstemmed The Current Role of Omega-3 Fatty Acids in the Management of Atrial Fibrillation
title_sort current role of omega-3 fatty acids in the management of atrial fibrillation
publisher MDPI AG
series International Journal of Molecular Sciences
issn 1422-0067
publishDate 2015-09-01
description Background: The main dietary source of omega-3 polyunsaturated fatty acids (n-3 PUFA) is fish, which contains eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). In the present manuscript, we aimed to review the current evidence regarding the clinical role of n-3 PUFA in the prevention of atrial fibrillation (AF) and the possible underlying mechanisms. Methods: A literature search based on PubMed listings was performed using “Omega-3 fatty acids” and “atrial fibrilation” as key search terms. Results: n-3 PUFA have been shown to attenuate structural atrial remodeling, prolong atrial effective refractory period through the prevention of reentry and suppress ectopic firing from pulmonary veins. Dietary fish intake has been found to have no effect on the incidence of AF in the majority of studies. Circulating DHA has been consistently reported to be inversely associated with AF risk, whereas EPA has no such effect. The majority of studies investigating the impact of n-3 PUFA supplementation on the incidence of AF following cardiac surgery reported no benefit, though most of them did not use n-3 PUFA pretreatment for adequate duration. Studies using adequate four-week pretreatment with n-3 PUFA before cardioversion of AF showed a reduction of the AF incidence. Conclusions: Although n-3 PUFA have antiarrhythmogenic properties, their clinical efficacy on the prevention of AF is not consistently supported. Further well-designed studies are needed to overcome the limitations of the existing studies and provide robust conclusions.
topic omega-3 fatty acids
eicosapentaenoic acid
docosahexaenoic acid
fish oil
atrial fibrillation
cardiac surgery
cardioversion
arrhythmia
url http://www.mdpi.com/1422-0067/16/9/22870
work_keys_str_mv AT georgiosachristou thecurrentroleofomega3fattyacidsinthemanagementofatrialfibrillation
AT konstantinosachristou thecurrentroleofomega3fattyacidsinthemanagementofatrialfibrillation
AT panagiotiskorantzopoulos thecurrentroleofomega3fattyacidsinthemanagementofatrialfibrillation
AT evangeloscrizos thecurrentroleofomega3fattyacidsinthemanagementofatrialfibrillation
AT dimitriosnnikas thecurrentroleofomega3fattyacidsinthemanagementofatrialfibrillation
AT johnagoudevenos thecurrentroleofomega3fattyacidsinthemanagementofatrialfibrillation
AT georgiosachristou currentroleofomega3fattyacidsinthemanagementofatrialfibrillation
AT konstantinosachristou currentroleofomega3fattyacidsinthemanagementofatrialfibrillation
AT panagiotiskorantzopoulos currentroleofomega3fattyacidsinthemanagementofatrialfibrillation
AT evangeloscrizos currentroleofomega3fattyacidsinthemanagementofatrialfibrillation
AT dimitriosnnikas currentroleofomega3fattyacidsinthemanagementofatrialfibrillation
AT johnagoudevenos currentroleofomega3fattyacidsinthemanagementofatrialfibrillation
_version_ 1725768567147724800